Literature DB >> 30590621

Current Understanding of Humoral Immunity to Enterovirus D68.

Matthew R Vogt1, James E Crowe1,2,3.   

Abstract

Enterovirus D68 (EV-D68) is a pathogen that causes outbreaks of respiratory illness across the world, mostly in children, and can be especially severe in those with asthma. Clusters of acute flaccid myelitis, a poliomyelitis-like neuromuscular weakness syndrome, often occur concurrent with EV-D68 respiratory outbreaks. Seroepidemiologic studies have found that the serum of nearly everyone older than 2 to 5 years contains anti-EV-D68 neutralizing antibodies, which suggests that EV-D68 is a ubiquitous pathogen of childhood. However, knowledge of the viral epitopes against which the humoral immune response is directed is only inferred from previous studies of related viruses. Although neutralizing antibodies protect newborn mice from lethal EV-D68 inoculation via nonphysiologic routes, cotton rats have a mixed phenotype of both benefit and possible exacerbation when inoculated intranasally. The human antibody response to EV-D68 needs to be studied further to clarify the role of antibodies in protection versus pathogenesis, which might differ among respiratory and neurologic disease phenotypes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30590621     DOI: 10.1093/jpids/piy124

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  7 in total

1.  Evolution, geographic spreading, and demographic distribution of Enterovirus D68.

Authors:  Emma B Hodcroft; Robert Dyrdak; Cristina Andrés; Adrian Egli; Josiane Reist; Diego García Martínez de Artola; Julia Alcoba-Flórez; Hubert G M Niesters; Andrés Antón; Randy Poelman; Marijke Reynders; Elke Wollants; Richard A Neher; Jan Albert
Journal:  PLoS Pathog       Date:  2022-05-31       Impact factor: 7.464

Review 2.  Acute Flaccid Myelitis: Something Old and Something New.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  mBio       Date:  2019-04-02       Impact factor: 7.867

3.  Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.

Authors:  Amy B Rosenfeld; Edmund Qian Long Shen; Michaela Melendez; Nischay Mishra; W Ian Lipkin; Vincent R Racaniello
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.786

4.  Setting the Stage for the Next Great Vaccine Success Story.

Authors:  Megan Culler Freeman
Journal:  mBio       Date:  2022-06-06       Impact factor: 7.786

5.  Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults, respectively, with both subclades exhibiting extensive genetic diversity.

Authors:  Hannah C Howson-Wells; Theocharis Tsoleridis; Izzah Zainuddin; Alexander W Tarr; William L Irving; Jonathan K Ball; Louise Berry; Gemma Clark; C Patrick McClure
Journal:  Microb Genom       Date:  2022-05

6.  Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.

Authors:  Matthew R Vogt; Jianing Fu; Nurgun Kose; Lauren E Williamson; Robin Bombardi; Ian Setliff; Ivelin S Georgiev; Thomas Klose; Michael G Rossmann; Yury A Bochkov; James E Gern; Richard J Kuhn; James E Crowe
Journal:  Sci Immunol       Date:  2020-07-03

7.  Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017.

Authors:  Jian-Te Lee; Wei-Liang Shih; Ting-Yu Yen; Ai-Ling Cheng; Chun-Yi Lu; Luan-Yin Chang; Li-Min Huang
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.